At the news
? NEUTRALIMPACT 3/10 8-K filed May 15, 2026 at 07:59 ET
Tandem Diabetes terminated EVP and Chief Commercial Officer Mark Novara without cause, effective May 18, 2026. The company emphasizes that its strategy and 2026 goals remain unchanged, suggesting the departure is isolated rather than a broader restructuring signal.
- Mark Novara, EVP and Chief Commercial Officer, terminated without cause
- Last day of employment is May 18, 2026
- Company states strategy and 2026 goals remain unchanged
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access